Ladra, Jane B.
HRN: 22-49-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2023
CEFUROXIME 500MG (TAB)
01/16/2023
01/23/2023
ORAL
500mg/tab
BID
S/P NSVD, PROM X 17 Hrs
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes